Florence Lee

Dr. Lee has been in the diagnostics industry in San Diego for over 10 years focusing on developing disruptive technologies with tangible impact on improving human health. She joined Truvian’s founding team over 6 years ago and executed foundational studies to demonstrate feasibility of the platform. Dr. Lee has led assay and algorithm development, and currently oversees clinical development and scientific affairs. Prior to Truvian, Dr. Lee was Director of Assay Development at Epic Sciences where she managed partnerships with pharmaceutical companies and developed immunofluorescent cell-based assay using Epic Sciences’ Circulating Tumor Cell detection platform. She also served as Director of Liquid Biopsy R&D at Biomatrica where her team developed a liquid biopsy blood collection tube to stabilize circulating tumor cells and cell free DNA.

Dr. Lee holds a B.S. in Biochemistry and a PhD in Biological Chemistry from University of California, Los Angeles. She performed her postdoctoral research at University of California, San Francisco in the areas of post-translational protein modification and developmental biology.